| NCT02920554 |
The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT02920554 |
Recruiting |
Saint Vincent’s Hospital, Korea |
2023-06-30 |
| NCT03278106 |
TAS-102 in Treating Advanced Biliary Tract Cancers |
https://ClinicalTrials.gov/show/NCT03278106 |
Active, not recruiting |
Mayo Clinic |
2018-11-30 |
| NCT03260712 |
Pembrolizumab in Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT03260712 |
Recruiting |
European Organisation for Research and Treatment of Cancer - EORTC |
2022-11-01 |
| NCT03257761 |
Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT03257761 |
Recruiting |
University of Southern California |
2021-02-07 |
| NCT03139487 |
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism |
https://ClinicalTrials.gov/show/NCT03139487 |
Recruiting |
Asan Medical Center |
2021-09-30 |
| NCT03111732 |
Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) |
https://ClinicalTrials.gov/show/NCT03111732 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2020-12-31 |
| NCT02867865 |
Perioperative Therapy Preoperative Chemotherapy Versus Chemoradiotherapy in Locally Advanced Gall Bladder Cancers |
https://ClinicalTrials.gov/show/NCT02867865 |
Recruiting |
Tata Memorial Hospital |
2021-08-31 |
| NCT02646514 |
Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study |
https://ClinicalTrials.gov/show/NCT02646514 |
Recruiting |
Yonsei University |
2019-09-30 |
| NCT02520141 |
Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02520141 |
Recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT02495896 |
Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT02495896 |
Active, not recruiting |
University of Southern California |
2020-02-28 |
| NCT02489422 |
Programs To Support You During Chemotherapy |
https://ClinicalTrials.gov/show/NCT02489422 |
Completed |
Wake Forest University Health Sciences |
2020-01-31 |
| NCT02430662 |
Irreversible Electroporation(IRE) For Unresectable Gallbladder Neoplasms |
https://ClinicalTrials.gov/show/NCT02430662 |
Recruiting |
Fuda Cancer Hospital, Guangzhou |
2020-12-01 |
| NCT02392637 |
Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers |
https://ClinicalTrials.gov/show/NCT02392637 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-04-30 |
| NCT02351765 |
ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers |
https://ClinicalTrials.gov/show/NCT02351765 |
Completed |
The Christie NHS Foundation Trust |
2019-03-31 |
| NCT02333188 |
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT02333188 |
Completed |
University of Chicago |
2017-12-31 |
| NCT02293954 |
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer |
https://ClinicalTrials.gov/show/NCT02293954 |
Active, not recruiting |
City of Hope Medical Center |
2020-06-30 |
| NCT02170090 |
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT02170090 |
Recruiting |
Universitätsklinikum Hamburg-Eppendorf |
2021-04-30 |
| NCT01313377 |
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01313377 |
Completed |
UNICANCER |
2016-06-30 |
| NCT01308840 |
Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT01308840 |
Completed |
University of Rochester |
2013-01-31 |
| NCT02042443 |
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT02042443 |
Completed |
National Cancer Institute (NCI) |
2017-01-31 |
| NCT01926236 |
Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers |
https://ClinicalTrials.gov/show/NCT01926236 |
Completed |
The Christie NHS Foundation Trust |
2018-01-05 |
| NCT01643499 |
Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies |
https://ClinicalTrials.gov/show/NCT01643499 |
Completed |
University of Chicago |
2016-08-28 |
| NCT01640522 |
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms |
https://ClinicalTrials.gov/show/NCT01640522 |
Completed |
University of Pittsburgh |
2013-12-31 |
| NCT01425879 |
MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01425879 |
Completed |
National Cancer Institute (NCI) |
2013-05-31 |
| NCT01320241 |
Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture |
https://ClinicalTrials.gov/show/NCT01320241 |
Completed |
Southeast University, China |
2012-03-31 |
| NCT04426669 |
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering |
https://ClinicalTrials.gov/show/NCT04426669 |
Recruiting |
Intima Bioscience, Inc. |
2022-10-31 |
| NCT04362449 |
Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration |
https://ClinicalTrials.gov/show/NCT04362449 |
Recruiting |
Imperial College Healthcare NHS Trust |
2021-01-02 |
| NCT04337333 |
Two-in-one Covered and Uncovered Metal Stent |
https://ClinicalTrials.gov/show/NCT04337333 |
Recruiting |
Ajou University School of Medicine |
2020-12-31 |
| NCT04333927 |
Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer |
https://ClinicalTrials.gov/show/NCT04333927 |
Active, not recruiting |
Sun Yat-sen University |
2024-06-30 |
| NCT04308174 |
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT04308174 |
Recruiting |
Asan Medical Center |
2021-09-30 |
| NCT04183712 |
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA |
https://ClinicalTrials.gov/show/NCT04183712 |
Recruiting |
Shanghai Jiao Tong University School of Medicine |
2021-05-31 |
| NCT04072445 |
Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT04072445 |
Recruiting |
Mayo Clinic |
2021-05-15 |
| NCT04068194 |
Testing the Combination of New Anti-cancer Drug Nedisertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies |
https://ClinicalTrials.gov/show/NCT04068194 |
Recruiting |
National Cancer Institute (NCI) |
2022-12-03 |
| NCT03985072 |
Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor |
https://ClinicalTrials.gov/show/NCT03985072 |
Recruiting |
Andes Biotechnologies |
2021-04-30 |
| NCT03833661 |
M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) |
https://ClinicalTrials.gov/show/NCT03833661 |
Active, not recruiting |
EMD Serono |
2020-11-09 |
| NCT03772132 |
Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma |
https://ClinicalTrials.gov/show/NCT03772132 |
Recruiting |
Shanghai Jiao Tong University School of Medicine |
2020-12-31 |
| NCT03768414 |
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers |
https://ClinicalTrials.gov/show/NCT03768414 |
Recruiting |
Southwest Oncology Group |
2024-01-01 |
| NCT03768375 |
Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma |
https://ClinicalTrials.gov/show/NCT03768375 |
Recruiting |
Shanghai Jiao Tong University School of Medicine |
2020-12-30 |
| NCT03702491 |
Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma |
https://ClinicalTrials.gov/show/NCT03702491 |
Recruiting |
Eastern Hepatobiliary Surgery Hospital |
2020-08-10 |
| NCT03673072 |
Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC |
https://ClinicalTrials.gov/show/NCT03673072 |
Recruiting |
Krankenhaus Nordwest |
2024-11-30 |
| NCT03473574 |
Durvalumab and Tremelimumab With Gemcitabine or Gemcitabine/Cisplatin Compared to Gemcitabine/Cisplatin in CCA Patients |
https://ClinicalTrials.gov/show/NCT03473574 |
Recruiting |
AIO-Studien-gGmbH |
2021-09-30 |
| NCT01242605 |
ABC-04 a Study of Cisplatin, Gemcitabine and Selumetinib in Patients With Advanced Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT01242605 |
Completed |
University College, London |
2013-03-31 |
| NCT01118897 |
Tomotherapy in Locally Advanced Gallbladder and Pancreatic Cancers |
https://ClinicalTrials.gov/show/NCT01118897 |
Completed |
Tata Memorial Hospital |
2013-01-31 |
| NCT01093222 |
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT01093222 |
Completed |
National Cancer Institute (NCI) |
2012-09-30 |
| NCT01053390 |
New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma |
https://ClinicalTrials.gov/show/NCT01053390 |
Completed |
Shanghai Jiao Tong University School of Medicine |
2013-12-31 |
| NCT01016639 |
Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer |
https://ClinicalTrials.gov/show/NCT01016639 |
Completed |
Lund University Hospital |
2007-07-31 |
| NCT00987766 |
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer |
https://ClinicalTrials.gov/show/NCT00987766 |
Completed |
Vanderbilt-Ingram Cancer Center |
2013-07-31 |
| NCT00949949 |
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy |
https://ClinicalTrials.gov/show/NCT00949949 |
Completed |
Mayo Clinic |
2014-07-31 |
| NCT00919061 |
Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy |
https://ClinicalTrials.gov/show/NCT00919061 |
Completed |
Memorial Sloan Kettering Cancer Center |
2014-03-31 |
| NCT04066491 |
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) |
https://ClinicalTrials.gov/show/NCT04066491 |
Recruiting |
EMD Serono |
2022-11-24 |
| NCT01825603 |
ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT01825603 |
Completed |
University of Nebraska |
2017-06-30 |
| NCT02836847 |
Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma |
https://ClinicalTrials.gov/show/NCT02836847 |
Recruiting |
Shanghai Jiao Tong University School of Medicine |
2019-12-31 |
| NCT02659852 |
A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction |
https://ClinicalTrials.gov/show/NCT02659852 |
Recruiting |
Yonsei University |
2020-01-31 |
| NCT00789958 |
S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct |
https://ClinicalTrials.gov/show/NCT00789958 |
Completed |
Southwest Oncology Group |
2014-12-31 |
| NCT00753675 |
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00753675 |
Completed |
Sanofi |
2012-09-30 |
| NCT00660699 |
A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers |
https://ClinicalTrials.gov/show/NCT00660699 |
Completed |
Washington University School of Medicine |
2010-09-30 |
| NCT00660140 |
Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00660140 |
Completed |
Washington University School of Medicine |
2007-01-31 |
| NCT00654160 |
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00654160 |
Completed |
Mayo Clinic |
2010-11-30 |
| NCT00544193 |
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00544193 |
Completed |
City of Hope Medical Center |
2012-08-31 |
| NCT00513539 |
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00513539 |
Completed |
University College, London |
2009-12-31 |
| NCT00486356 |
Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00486356 |
Completed |
University of Nebraska |
2010-01-31 |
| NCT00423254 |
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. |
https://ClinicalTrials.gov/show/NCT00423254 |
Completed |
Mannkind Corporation |
2009-09-30 |
| NCT00409864 |
Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer |
https://ClinicalTrials.gov/show/NCT00409864 |
Completed |
All India Institute of Medical Sciences, New Delhi |
2005-07-31 |
| NCT00397384 |
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00397384 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT00391183 |
Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block. |
https://ClinicalTrials.gov/show/NCT00391183 |
Completed |
All India Institute of Medical Sciences, New Delhi |
2012-12-31 |
| NCT00363584 |
Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00363584 |
Completed |
National Cancer Institute (NCI) |
2013-08-31 |
| NCT00361231 |
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00361231 |
Completed |
Massachusetts General Hospital |
2009-03-31 |
| NCT00356889 |
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors |
https://ClinicalTrials.gov/show/NCT00356889 |
Completed |
National Cancer Institute (NCI) |
2008-10-31 |
| NCT00350753 |
Avastin and Tarceva for Upper Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT00350753 |
Completed |
Rigshospitalet, Denmark |
2009-06-30 |
| NCT00338988 |
Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00338988 |
Completed |
M.D. Anderson Cancer Center |
2009-05-31 |
| NCT00304135 |
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00304135 |
Completed |
Federation Francophone de Cancerologie Digestive |
2012-12-31 |
| NCT00280709 |
Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction |
https://ClinicalTrials.gov/show/NCT00280709 |
Completed |
University Hospital, Linkoeping |
2008-10-31 |
| NCT00266097 |
Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00266097 |
Completed |
UNC Lineberger Comprehensive Cancer Center |
2009-03-31 |
| NCT00262769 |
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors |
https://ClinicalTrials.gov/show/NCT00262769 |
Completed |
University College, London |
2008-08-31 |
| NCT00238212 |
S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00238212 |
Completed |
National Cancer Institute (NCI) |
2007-01-31 |
| NCT00142480 |
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00142480 |
Completed |
Massachusetts General Hospital |
2007-07-31 |
| NCT00123825 |
Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00123825 |
Completed |
Dana-Farber Cancer Institute |
2007-10-31 |
| NCT00107536 |
Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00107536 |
Completed |
National Cancer Institute (NCI) |
2009-05-31 |
| NCT00101036 |
Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00101036 |
Completed |
National Cancer Institute (NCI) |
2009-01-31 |
| NCT00003557 |
Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00003557 |
Completed |
University of Chicago |
2000-06-30 |
| NCT00084942 |
Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder |
https://ClinicalTrials.gov/show/NCT00084942 |
Completed |
Roswell Park Cancer Institute |
2004-05-31 |
| NCT00004604 |
Biological Therapy in Treating Patients With Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00004604 |
Completed |
Duke University |
2001-06-30 |
| NCT00003427 |
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00003427 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-04-30 |
| NCT00005938 |
DX-8951f in Treating Patients With Biliary Cancer |
https://ClinicalTrials.gov/show/NCT00005938 |
Completed |
Daiichi Sankyo, Inc. |
2005-04-30 |
| NCT00003411 |
Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT00003411 |
Completed |
University of Pittsburgh |
2002-06-30 |
| NCT00003046 |
Interleukin-12 in Treating Patients With Cancer in the Abdomen |
https://ClinicalTrials.gov/show/NCT00003046 |
Completed |
M.D. Anderson Cancer Center |
2001-10-31 |
| NCT00003923 |
Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas |
https://ClinicalTrials.gov/show/NCT00003923 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-02-28 |
| NCT00075504 |
Triapine and Gemcitabine Hydrochloride in Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00075504 |
Completed |
National Cancer Institute (NCI) |
2009-01-31 |
| NCT00009893 |
Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00009893 |
Completed |
Alliance for Clinical Trials in Oncology |
2005-01-31 |
| NCT00073905 |
Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer |
https://ClinicalTrials.gov/show/NCT00073905 |
Completed |
Swiss Group for Clinical Cancer Research |
2006-06-30 |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00033462 |
Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00033462 |
Completed |
National Cancer Institute (NCI) |
2006-11-30 |
| NCT00059865 |
Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer |
https://ClinicalTrials.gov/show/NCT00059865 |
Completed |
Alliance for Clinical Trials in Oncology |
2007-02-28 |
| NCT00033540 |
S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT00033540 |
Completed |
Southwest Oncology Group |
2008-04-30 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00028496 |
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00028496 |
Completed |
National Cancer Institute (NCI) |
2005-11-30 |
| NCT00027534 |
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00027534 |
Completed |
Duke University |
2007-10-31 |
| NCT00019513 |
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00019513 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00003276 |
Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer |
https://ClinicalTrials.gov/show/NCT00003276 |
Completed |
Alliance for Clinical Trials in Oncology |
2001-03-31 |